Europe Magnetic Resonance Imaging (MRI) Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Europe Magnetic Resonance Imaging (MRI) Devices Market Segmentation, By Type: Conventional, Bio-based , By Field Strength: High-Field Magnetic Resonance Imaging (MRI) Systems (1.5t to 3t), Low-To-Mid-Field Magnetic Resonance Imaging (MRI) Systems (<1.5t), Very-High-Field Magnetic Resonance Imaging (MRI) Systems (4t and Above) , By Architecture: Closed Magnetic Resonance Imaging (MRI), Standard Bore Magnetic Resonance Imaging (MRI), Wide-Bore Magnetic Resonance Imaging (MRI), Open Magnetic Resonance Imaging (MRI) , By Modality: Stationary System, Portable/Mobile System, Point-of-Care (POC) System , By Application: Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, Other Applications , By End-User: Hospitals, Imaging Centers, Ambulatory Surgical Centers, Other End Users Country (Germany, France, U.K., Italy, Spain, Russia, Switzerland, Belgium, Netherlands, Turkey, Rest of Europe) - Industry Trends and Forecast to 2032

Magnetic Resonance Imaging (MRI) Devices Market Size

• The Europe Magnetic Resonance Imaging (MRI) Devices market size was valued at USD 2.67 billion in 2024 and is expected to reach USD 3.89 billion by 2032, at a CAGR of 7.20% during the forecast period
• The market's growth is largely fueled by the increasing aging population, the rising prevalence of chronic diseases, and the growing emphasis on early diagnosis.
• Furthermore, the introduction of hybrid MRI systems and the availability of universal health coverage in Europe are encouraging people to undergo tests or treatments at regular intervals, significantly boosting the industry's growth.

Magnetic Resonance Imaging (MRI) Devices Market Analysis

• The market's growth is largely fueled by the increasing aging population, the rising prevalence of chronic diseases, and the growing emphasis on early diagnosis.
• Furthermore, the introduction of hybrid MRI systems and the availability of universal health coverage in Europe are encouraging people to undergo tests or treatments at regular intervals, significantly boosting the industry's growth.
• Germany dominates the Magnetic Resonance Imaging (MRI) Devices Market with the largest revenue share of 54.5% in 2024, due to The market's growth is largely fueled by the increasing aging population, the rising prevalence of chronic diseases, and the growing emphasis on early diagnosis.
• The Conventional segment is expected to dominate the Magnetic Resonance Imaging (MRI) Devices Market with a market share of 59.99% in 2024, due to the increasing use of MRI machines in various fields such as gynecology, urology, dentistry, cardiology, musculoskeletal, cancer, pelvic and abdominal. The country's diagnostic imaging services, including MRI scans, are also cost-effective compared to other European countries like the UK.

Report Scope and Magnetic Resonance Imaging (MRI) Devices Market Segmentation        

Magnetic Resonance Imaging (MRI) Devices Market Trends

“Advancements in Digital and AI-Powered MRI Systems”

• A significant trend in the Europe Magnetic Resonance Resonance Imaging (MRI) devices market is the rapid advancement and adoption of digital and AI-powered MRI systems. These innovations are revolutionizing the industry by improving image quality, scanning speed, and diagnostic accuracy.

  • For instance, in February 2024, Fujifilm Healthcare Europe launched its new 1.5 Tesla superconductive MRI scanner, Echelon Synergy, featuring AI-powered deep learning for enhanced image sharpness and scanning speed. Similarly, in November 2023, Royal Philips launched its inaugural mobile MRI system, BlueSeal MR Mobile, featuring helium-free operations, which prioritizes patient-centric MRI services and aims to extend accessible, sustainable, and helium-free MRI exams to diverse locations.

• The integration of AI in MRI systems facilitates automated image reconstruction, noise reduction, and intelligent workflow optimization, leading to more efficient examinations and better patient outcomes.
• Furthermore, remote scanning capabilities, as highlighted by Philips' Radiology Operations Command Center Console receiving its EU Medical Device Regulation (MDR) certificate in February 2025, are enabling expert radiologists to assist technologists on-site by remotely controlling scans, improving efficiency and access to specialized care across Europe.

Magnetic Resonance Imaging (MRI) Devices Market Dynamics

Driver

“Rising Prevalence of Chronic Diseases and Aging Population”

• The increasing prevalence of chronic diseases such as cancer, neurological disorders (e.g., dementia, Alzheimer's, Parkinson's), cardiovascular diseases, and musculoskeletal conditions, coupled with a rapidly aging population in Europe, is a major driver for the MRI devices market.

  • For instance, as per Eurostats Statistics in February 2022, over one-fifth (20.8%) of European citizens were 65 years of age or older in 2021, and this proportion is projected to increase to 14.6% by 2100 for those aged 80 or older. This demographic shift significantly increases the demand for diagnostic imaging as older individuals are more susceptible to age-related health issues requiring MRI scans for accurate diagnosis and monitoring.

• MRI's ability to provide detailed soft tissue contrast makes it invaluable for the early detection and management of these complex conditions. Universal health coverage in many European countries also makes MRI scans more accessible and affordable, further encouraging their use.
• Furthermore, advancements in MRI technology, such as the introduction of hybrid systems and personalized care approaches, continue to expand its utility in diagnosing and managing a broader spectrum of chronic illnesses.

Restraint/Challenge

“High Cost of MRI Systems and Declining Helium Availability”

• The high initial acquisition and installation costs of MRI systems, coupled with ongoing maintenance expenses, pose a significant restraint on market growth, particularly for smaller healthcare facilities or those with limited budgets.

  • For instance, advanced high-field MRI systems require substantial capital investment, making them less accessible in some regions or for certain healthcare providers. Moreover, the scarcity and fluctuating prices of helium, a critical cryogenic gas essential for cooling superconducting MRI magnets, present a significant challenge. This supply chain vulnerability can increase operating costs and potentially disrupt MRI services.

• While advancements in helium-free or low-helium MRI technologies are emerging to mitigate this issue, the transition can be costly and time-consuming.
• Additionally, stringent regulatory frameworks and the need for highly skilled personnel to operate and maintain MRI devices further contribute to the overall operational complexities and costs, challenging widespread adoption, especially in regions with limited healthcare resources.

Magnetic Resonance Imaging (MRI) Devices Market Scope

The market is segmented on the basis of type, field strength, architecture, modality, application, and end-user.

By Type

On the basis of type, the Europe magnetic resonance imaging (MRI) devices market is segmented into conventional and bio-based. The conventional segment is anticipated to hold the market share of 48.34% in 2025 driven by their increasing use in advanced research and specialized clinical applications, particularly in neurology and oncology.

The bio-based segment is anticipated to hold the market share of 38.45% in 2025 driven by the increasing demand for patient comfort, especially for claustrophobic, obese, geriatric, and pediatric patients.

By Field Strength

On the basis of field strength, the Europe magnetic resonance imaging (MRI) devices market is segmented into high-field magnetic resonance imaging (MRI) systems (1.5t to 3t), low-to-mid-field magnetic resonance imaging (MRI) systems (<1.5t), and very-high-field magnetic resonance imaging (MRI) systems (4t and above). The high-field MRI systems (1.5T to 3T) segment is estimated to hold a significant share due to their superior image quality and diagnostic capabilities, making them widely adopted for various clinical applications.

The very-high-field MRI systems (4T and above) segment is expected to witness substantial growth, driven by their increasing use in advanced research and specialized clinical applications, particularly in neurology and oncology.

By Architecture

On the basis of architecture, the Europe magnetic resonance imaging (MRI) devices market is segmented into closed magnetic resonance imaging (MRI), standard bore magnetic resonance imaging (MRI), wide-bore magnetic resonance imaging (MRI), and open magnetic resonance imaging (MRI). The closed MRI systems segment holds a significant share due to their widespread installation base and ability to produce high-quality images.

The open magnetic resonance imaging (MRI) segment is anticipated to grow with a high CAGR, driven by the increasing demand for patient comfort, especially for claustrophobic, obese, geriatric, and pediatric patients.

By Modality

On the basis of modality, the Europe magnetic resonance imaging (MRI) devices market is segmented into stationary system, portable/mobile system, and point-of-care (POC) system. The stationary system segment is expected to hold the largest share due to its established presence in hospitals and diagnostic centers for comprehensive imaging needs.

The portable/mobile system segment is anticipated to grow with a high CAGR, driven by the increasing need for flexible and accessible MRI services in various healthcare settings, including remote areas and emergency situations.

By Application

On the basis of application, the Europe magnetic resonance imaging (MRI) devices market is segmented into oncology, neurology, cardiology, gastroenterology, musculoskeletal, and other applications. The neurology segment is expected to dominate, owing to the rising prevalence of neurological disorders and the indispensable role of MRI in brain and spinal cord imaging.

 The oncology segment is anticipated to grow with a high CAGR, driven by the increasing use of MRI for cancer detection, staging, and treatment monitoring.

By End-User

On the basis of end-user, the Europe magnetic resonance imaging (MRI) devices market is segmented into hospitals, imaging centers, ambulatory surgical centers, and other end users. The hospitals segment is expected to hold the largest market share, attributed to their extensive infrastructure, high patient volume, and the need for comprehensive diagnostic capabilities.

The imaging centers segment is anticipated to grow with a high CAGR, driven by their specialization in diagnostic services and increasing patient referrals for various imaging procedures.

Magnetic Resonance Imaging (MRI) Devices Market Regional Analysis

• Germany dominates the Magnetic Resonance Imaging (MRI) Devices market with the largest revenue share of 54.5% in 2024, due to its sophisticated healthcare system, strong emphasis on research and development activities, and a high volume of MRI procedures performed for various conditions.
• The country's extensive network of doctors and hospitals, even in remote areas, ensures widespread access to advanced medical imaging services.

France Magnetic Resonance Imaging (MRI) Devices Market Insight

The France Magnetic Resonance Imaging (MRI) Devices market is driven by significant healthcare expenditure and a focus on integrating advanced imaging technologies. The country's robust healthcare infrastructure and increasing awareness among the population regarding early disease diagnosis are key factors fueling market growth.

U.K. Magnetic Resonance Imaging (MRI) Devices Market Insight

The U.K. Magnetic Resonance Imaging (MRI) Devices market is driven by the presence of a sophisticated healthcare system, such as the National Health Services (NHS), coupled with a growing geriatric population and increasing prevalence of chronic diseases. The rising demand for early and accurate diagnosis contributes to market growth in the U.K.

Magnetic Resonance Imaging (MRI) Devices Market Share

The Magnetic Resonance Imaging (MRI) Devices industry is primarily led by well-established companies, including:

• BD (U.S.)
• bioMérieux SA (France)
• Thermo Fisher Scientific Inc. (U.S.)
• Bruker Corporation (U.S.)
• Danaher Corporation (U.S.)
• Roche Diagnostics (Switzerland)
• T2 Biosystems (U.S.)
• Luminex Corporation (U.S.)
• Siemens Healthineers AG (Germany)
• Abbott Laboratories (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• GE Healthcare (U.S.)
• FUJIFILM Corporation (Japan)
• Canon Medical Systems Corporation (Japan)

Latest Developments in Europe Magnetic Resonance Imaging (MRI) Devices Market

• In November 2023 ,Koninklijke Philips N.V. expanded the partnership agreement with SyntheticMR, which aims to introduce SyMRI 3D. The development would further expand the company’s imaging product offering.
• In November 2023, GE Healthcare launched a 1.5T wide bore Magnetic Resonance Imaging (MRI) system, SIGNA Champion. The system is designed to improve the standard of care for patients by integrating advanced AI and innovative features that enable faster and more precise MRI scans.
• In August 2023, FUJIFILM Corporation launched a new 1.5Tesla MRI system, ECHELON Synergy, integrated with deep learning reconstruction technology. This advanced technology will enhance the image quality and patient satisfaction.
• In April 2023, Canon Medical Systems Corporation launched an AI-automated MRI planning solution to accelerate MRI planning time. The system utilizes machine learning and deep learning to improve diagnostic imaging of prostate, liver, and whole spine examinations.

SKU-1891